Monday, July 30, 2012

Drug Combo Tackling Solid Tumors

›
Cancer Research UK's Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tu...
Sunday, July 29, 2012

Takeda announces updated results from orteronel phase 2 study on nmCRPC

›
Takeda announces updated results from orteronel phase 2 study on nmCRPC : Millennium: The Takeda Oncology Company with its parent com...
Saturday, July 28, 2012

Antisense Pharma presents data from trabedersen Phase I/II cancer study at ASCO 2012

›
In continuation of my update on antisense drugs Trabedersen, is an antisense compound that specifically inhibits expression of trans...
Friday, July 27, 2012

Ancient berry could protect against diabetic retinopathy

›
In continuation of my update on wolfberry Ancient berry could protect against diabetic retinopathy : The ancient Tibetan goji berry co...
Thursday, July 26, 2012

Dapivirine Phase III trial now underway in Africa to treat HIV in women

›
Dapivirine Phase III trial now underway in Africa to treat HIV in women

Investigational diabetes drug appears to improve insulin sensitivity without side effects

›
Drugs for type 2 diabetes can contribute to weight gain, bone fractures and cardiovascular problems, but in mice, an investigational d...
Wednesday, July 25, 2012

Cyclacel Presents New Phase 2 Data of Sapacitabine for MDS

›
We know that, Sapacitabine is an oral nucleoside analog prodrug that acts through a dual mechanism. The compound interferes with DNA sy...
Tuesday, July 24, 2012

For advanced prostate cancer, new drug slows disease

›
In continuation of my update on  abiraterone The study is the first randomized clinical trial to document expanded benefits among a pa...
1 comment:
Monday, July 23, 2012

RA Study Misses Primary Endpoint (CH-4051)...

›
In continuation of my update on CH-4051 Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that a preliminary analysis of...
Sunday, July 22, 2012

Thioridazine drug successfully kills human cancer stem cells

›
Thioridazine drug successfully kills human cancer stem cells : A team of scientists at McMaster University has discovered a drug, thio...
Saturday, July 21, 2012

Onyx receives FDA approval for Kyprolis to treat multiple myeloma

›
  In continuation of my update on  Kyprolis ....... Onyx receives FDA approval for Kyprolis to treat multiple myeloma : The Multiple Myelom...

FDA approves Cipher’s Absorica to treat severe recalcitrant nodular acne

›
FDA approves Cipher’s Absorica to treat severe recalcitrant nodular acne : Cipher Pharmaceuticals Inc. announced today that the U.S. Foo...
Friday, July 20, 2012

APD421 Reduces Nausea, Vomiting....

›
Acacia Pharma announces positive results from its Phase 2 study of APD421, in the prevention of post-operative nausea and vomiting (PO...
Thursday, July 19, 2012

FDA accepts NDA filing for KYNAMRO to treat HoFH...

›
In continuation of my update on Mipomersen ... Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc., announced,  that the U.S. ...
Wednesday, July 18, 2012

Diabetes Drug Could Be a Promising Therapy for Traumatic Brain Injury

›
In continuation of my update on Exendin-4 Research commissioned by the United States Air Force,   Prof. Chaim Pick   of   Tel Aviv Un...